Kiniksa Pharmaceuticals Chief Medical Officer Paolini John F. exercised Options for 8,328 shares on 2026-09-01. The transactions also followed awards of 33,450 derivative securities and left him with 0 derivative securities, while his reported share ownership was 69,922 after a 4,029-share forfeiture at $79.28 per share.

Key Highlights

  • Paolini John F. forfeited 4,029 Kiniksa shares at $79.28 per share on 1 September 2026.
  • Kiniksa awarded Paolini John F. 33,450 derivative securities at $0 per share.
  • Paolini John F. reported 0 derivative securities after exercising options.

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) Chief Medical Officer Paolini John F. exercised options for 8,328 shares on 1 September 2026. His reported share ownership after those exercises was 73,951.

$79.28 Share Forfeiture and Derivative Awards

Paolini separately forfeited 4,029 shares at $79.28 per share on 1 September 2026, after which his reported share ownership was 69,922. Following those awards, Paolini’s derivative holdings were 26,750. He then exercised options covering 8,328 derivative securities at $0 per share. His derivative securities ownership after those exercises was 0.